| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |